CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Terlipressin in 33 Patients with Hepatorenal Syndrome: Results of a Retrospective Study on Duration and Dose of Terlipressin Therapy
DOI 10.1055/s-2008-1037659
Bibliografische Angaben
Nachweis in CareLit
Autor:innenV von Kalckreuth, F Glowa, AW Lohse, U Denzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Terlipressin is known to improve renal function in patients with liver cirrhosis and hepatorenal syndrome (HRS). This study investigated retrospectively effects of duration and dose of terlipressin therapy and predictive factors for positive response to treatment. Methods: HRS was defined as increase in serum creatine value >1.5mg/dL and decrease of glomerular filtration rate to
Zitieren
Zitierempfehlung
V von Kalckreuth, F Glowa, AW Lohse, U Denzer (2008) Terlipressin in 33 Patients with Hepatorenal Syndrome: Results of a Retrospective Study on Duration and Dose of Terlipressin Therapy. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2008-1037659
Mit CareLit weiterarbeiten